Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Automatic liver tumor segmentation on computed tomography for patient treatment planning and monitoring.

Moghbel M, Mashohor S, Mahmud R, Saripan MI.

EXCLI J. 2016 Jun 27;15:406-23. doi: 10.17179/excli2016-402. eCollection 2016.

2.

Risk factors for deterioration of long-term liver function after radiofrequency ablation therapy.

Honda K, Seike M, Oribe J, Endo M, Arakawa M, Syo H, Iwao M, Tokoro M, Nishimura J, Mori T, Yamashita T, Fukuchi S, Muro T, Murakami K.

World J Hepatol. 2016 May 8;8(13):597-604. doi: 10.4254/wjh.v8.i13.597.

3.

Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map.

Tani S, Tatli S, Hata N, Garcia-Rojas X, Olubiyi OI, Silverman SG, Tokuda J.

Int J Comput Assist Radiol Surg. 2016 Jun;11(6):1133-42. doi: 10.1007/s11548-016-1398-z. Epub 2016 Apr 2.

4.

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review.

Marin D, Cappabianca S, Serra N, Sica A, Lassandro F, D'Angelo R, La Porta M, Fiore F, Somma F.

Gastroenterol Res Pract. 2015;2015:670965. doi: 10.1155/2015/670965. Epub 2015 Dec 22. Review.

5.

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil.

Ueshima K, Kudo M, Tanaka M, Kumada T, Chung H, Hagiwara S, Inoue T, Yada N, Kitai S.

Liver Cancer. 2015 Dec;4(4):263-73. doi: 10.1159/000367751. Epub 2015 Oct 21.

6.

Cryoablation Versus Radiofrequency Ablation for Hepatic Malignancies: A Systematic Review and Literature-Based Analysis.

Wu S, Hou J, Ding Y, Wu F, Hu Y, Jiang Q, Mao P, Yang Y.

Medicine (Baltimore). 2015 Dec;94(49):e2252. doi: 10.1097/MD.0000000000002252. Review.

7.

Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center.

Labori KJ, Schulz A, Drolsum A, Guren MG, Kløw NE, Bjørnbeth BA.

Acta Radiol Open. 2015 Jul 6;4(7):2058460115580877. doi: 10.1177/2058460115580877. eCollection 2015 Jul.

8.

Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.

Wang XL, Li K, Su ZZ, Huang ZP, Wang P, Zheng RQ.

World J Gastroenterol. 2015 May 7;21(17):5345-51. doi: 10.3748/wjg.v21.i17.5345.

9.

Recent advances in multidisciplinary management of hepatocellular carcinoma.

Gomaa AI, Waked I.

World J Hepatol. 2015 Apr 8;7(4):673-87. doi: 10.4254/wjh.v7.i4.673. Review.

10.

Role of local ablative therapy for hepatocellular carcinoma.

Thandassery RB, Goenka U, Goenka MK.

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S104-11. doi: 10.1016/j.jceh.2014.03.046. Epub 2014 Apr 1. Review.

11.

Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.

Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH.

World J Gastroenterol. 2015 Feb 7;21(5):1554-66. doi: 10.3748/wjg.v21.i5.1554.

12.

CT imaging during microwave ablation: analysis of spatial and temporal tissue contraction.

Liu D, Brace CL.

Med Phys. 2014 Nov;41(11):113303. doi: 10.1118/1.4897381.

13.

Design and validation of a thermoreversible material for percutaneous tissue hydrodissection.

Johnson A, Sprangers A, Cassidy P, Heyrman S, Hinshaw JL, Lubner M, Puccinelli J, Brace C.

J Biomed Mater Res B Appl Biomater. 2013 Nov;101(8):1400-9. doi: 10.1002/jbm.b.32959.

14.

The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients.

Xie H, Wang H, An W, Ma W, Qi R, Yang B, Liu C, Gao Y, Xu B, Wang W.

PLoS One. 2014 Feb 20;9(2):e89081. doi: 10.1371/journal.pone.0089081. eCollection 2014.

15.

Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats.

Imaeda M, Ishikawa H, Yoshida Y, Takahashi T, Ohkubo Y, Musha A, Komachi M, Nakazato Y, Nakano T.

J Radiat Res. 2014 Jul;55(4):665-73. doi: 10.1093/jrr/rru005. Epub 2014 Feb 23.

16.

Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Zhang Y, White SB, Nicolai JR, Zhang Z, West DL, Kim DH, Goodwin AL, Miller FH, Omary RA, Larson AC.

Radiology. 2014 Jun;271(3):721-9. doi: 10.1148/radiol.14130989. Epub 2014 Feb 18.

17.

Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.

Ishikawa T.

World J Gastroenterol. 2013 Dec 21;19(47):8861-6. doi: 10.3748/wjg.v19.i47.8861. Review.

18.

CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.

Ohki T, Tateishi R, Akahane M, Mikami S, Sato M, Uchino K, Arano T, Enooku K, Kondo Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Matsuyama Y, Omata M, Ohtomo K, Koike K.

Am J Gastroenterol. 2013 Aug;108(8):1305-13. doi: 10.1038/ajg.2013.109. Epub 2013 Apr 30.

19.

Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.

Tateishi R, Shiina S, Akahane M, Sato J, Kondo Y, Masuzaki R, Nakagawa H, Asaoka Y, Goto T, Otomo K, Omata M, Yoshida H, Koike K.

PLoS One. 2013 Apr 12;8(4):e59040. doi: 10.1371/journal.pone.0059040. Print 2013.

20.

Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma.

Cheung TT, Fan ST, Chu FS, Jenkins CR, Chok KS, Tsang SH, Dai WC, Chan AC, Chan SC, Yau TC, Poon RT, Lo CM.

HPB (Oxford). 2013 Aug;15(8):567-73. doi: 10.1111/hpb.12025. Epub 2012 Dec 4.

Items per page

Supplemental Content

Write to the Help Desk